Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Sep;21(5):369-374.
doi: 10.2450/BloodTransfus.503. Epub 2023 Mar 17.

Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Hasan Tahsin Özpolat  1 , Moritz Stolla  1   2   3
Affiliations
Comment

Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Hasan Tahsin Özpolat et al. Blood Transfus. 2023 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflict of interest.

Figures

Figure 1
Figure 1
There are three different indications of using rituximab in the treatment of iTTP PLEX: plasma exchange; CS: corticosteroid.
See this image and copyright information in PMC

Comment on

References

    1. Furlan M, Robles R, Solenthaler M, Lammle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood. 1998;91:2839–2846. doi: 10.1182/blood.V91.8.2839.2839_2839_2846. - DOI - PubMed
    1. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339:1585–1594. doi: 10.1056/NEJM199811263392203. - DOI - PMC - PubMed
    1. Scully M, Cataland S, Coppo P, et al. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost. 2017;15:312–322. doi: 10.1111/jth.13571. - DOI - PubMed
    1. Shumak KH, Rock GA, Nair RC Canadian Apheresis Group. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Ann Intern Med. 1995;122:569–572. doi: 10.7326/0003-4819-122-8-199504150-00002. - DOI - PubMed
    1. Bandarenko N, Brecher ME United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apher. 1998;13:133–141. doi: 10.1002/(sici)1098-1101(1998)13:3<133::aid-jca7>3.0.co;2-z. - DOI - PubMed

LinkOut - more resources